References
- Balen A. H., Michelmore K. What is polycystic ovary syndrome? Are national views important?. Human Reproduction 2002; 17: 2219–2227
- Cedergren M. I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstetrics & Gynecology 2004; 103: 219–224
- CEMACH: Confidential Enquiry into Maternal and Child Health: Pregnancy in Women with Type 1 and Type 2 Diabetes in 2002 – 2003, England,Wales and Northern Ireland. CEMACH, London 2005
- Why Mothers Die 2000 – 2002, G. Lewis. Confidential Enquiry into Maternal and Child Health, London 2004
- Linne Y. Effects of obesity on women's reproduction and complications during pregnancy. Obesity Reviews 2004; 5: 137–143
- Lord J. M., Flight I. H., Norman R. J. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome The Cochrane Database of Systematic Reviews 2003, Issue 2. 2003, Art. No.: CD003053. DOI: 10.1002/14651858. CD003053
- National Institute for Clinical Excellence (NICE). Fertility assessment and treatment for people with fertility problems. A clinical guideline. RCOG Press, London 2004
- Norman R. J., Noakes M., Wu R., Davies M. J., Moran L, Wang J. X. Improving reproductive performance in overweight/obese women with effective weight management. Human Reproduction Update 2004; 10: 267–280
- Pasquali R., Antenucci D., Caimirri F., Venturoli S., Paradis R, Fabbri R. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. Journal of Clinical Endocrinology & Metabolism 1989; 68: 173–179
- Radon P. A., McMahon M. J., Meyer W. R. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstetrics & Gynecology 1999; 94: 194–197
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction 2004; 19: 41–47, Fertility & Sterility, 81, 19 – 25
- Tang T., Glanville J., Hayden C. J., White D., Barth J. H., Balen A. H. Combined life-style modification and metformin in obese patients with polycystic ovary syndrome (PCOS). A randomised, placebo-controlled, double-blind multi-centre study. Human Reproduction 2005, (November, advanced access published on the web: doi:doi10.1093/humprep/dei311)
References
- Hammer-Burns L., Covington S. Infertility Counselling: A Comprehensive Handbook for Clinicians. Parthenon Publishing Group, London 1999
- Leiblum S. Infertility: Psychological issues and counselling strategies. John Wiley & Sons, New York 1998
- van den Akker O. B. A. The Complete Guide to Infertility: Diagnosis, Treatment, Options. Free Association Books, UK 2002
References
- Balen A. H., Jacobs H. S. Infertility in practice2nd ed. Churchill Livingstone, London 2003
- Dor J., Lerner-Geva L., Rabinovici J., Chetrit A., Levran D., Lunenfeld B., Mashiach S., Modan B. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertility & Sterility 2002; 77: 324–327
- Gibson D., Myers J. The effect of social coping resources and growth-fostering relationships on infertility stress in women. Journal of Mental Health Counseling 2002; 24: 64–80
- Land J. A. Ovulation, ovulation induction and ovarian carcinoma. Baillieres Clinical Obstetrics & Gynaecology 1993; 7: 455–472
- Lockwood G. M. Philosophical principles in reproductive medicine. Human Fertility 1998; 1: 27–29
- McGinn K. A., Haylock P. J. Women's cancers. How to prevent them. How to treat them. How to beat them. Hunter House, Inc., Alameda, CA 1998
- MacLean A. B. Epithelial ovarian cancer and infertility treatment. Journal of Obstetrics & Gynaecology 2002; 22: 7–8
- Nicto J. J., Rolfe K. J., MacLean A. B., Hardiman P. Ovarian cancer and infertility: a genetic link?. Lancet 1999; 354(9179)649
- Ponder B. A. J. The inherited contribution to ovarian cancer. Ovarian Cancer 4, R. Leake, A. Blackett, F. Sharpe. Chapman & Hall, London 1996; 75–80
- Rossing M. A., Daling J. R., Weiss N. S., Moore D. E., Self S. G. Ovarian tumors in a cohort of infertile women. New England Journal of Medicine 1994; 331: 771–776
- Shushan A., Paltiel O., Iscovich J., Elchalal U., Peretz T., Schemker J. G. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertility & Sterility 1996; 65: 13–18
- Tarlatzis B. B, Kolibianakis E. M. Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Reproductive Biomedicine Online 2002; 5(Suppl. 1)8–13
- Venn A., Watson L., Bruinsma F., Giles G., Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999; 354(9190)1586–1590
- Venn A., Watson L., Lumley J., Giles G., King C., Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346(8981)995–1000
- Willemsen W., Kruitwagen R., Bastiaans B., Hanselaar T., Rolland R. Ovarian stimulation and granulosa-cell tumour. Lancet 1993; 341(8851)986–988
References
- Daya S., Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database of Systematic Reviews 2004; 3, CD004830
- Nosarka S., Kruger T., Siebert I., Grove D. Luteal phase support in in vitro fertilization: meta-analysis of randomized trials. Gynecologic & Obstetric Investigation 2005; 60: 67–74